Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295008 · ClinicalTrials.gov registry record
Androgenetic Alopecia in Fabry Disease
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 107
- Enrollment target
NCT01295008: Completed study, sponsored by Baylor Research Institute.
NCT01295008 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01295008 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether patients with the classic form of Fabry disease have significantly less androgenic alopecia (male pattern baldness).
Primary Outcome
No and frontal only androgenetic alopecia opposed to vertex only and frontal and vertex androgenetic alopecia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-10 |
What the finished NCT01295008 record still lists
NCT01295008 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01295008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01295008 about?
NCT01295008 is a clinical study titled "Androgenetic Alopecia in Fabry Disease". The purpose of this study is to assess whether patients with the classic form of Fabry disease have significantly less androgenic alopecia (male pattern baldness).
What is the current status of trial NCT01295008?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2010-12. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01295008?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia